Accuray (ARAY) Cash from Operations Growth (1y) (2011 - 2026)
Accuray (ARAY) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -12.60% |
| 10 | Accuray | 36.52 Mn | -3.18 Mn | 25.29 Mn | -144.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -144.57% |
| Dec 31, 2025 | -987.62% |
| Sep 30, 2025 | 266.99% |
| Mar 31, 2025 | 157.69% |
| Dec 31, 2024 | 135.36% |
| Sep 30, 2024 | 15.10% |
| Mar 31, 2024 | -427.22% |
| Dec 31, 2023 | 71.73% |
| Sep 30, 2023 | -18,776.09% |
| Mar 31, 2023 | 196.70% |
| Dec 31, 2022 | -155.24% |
| Sep 30, 2022 | 100.53% |
| Mar 31, 2022 | -93.06% |
| Dec 31, 2021 | 69.11% |
| Sep 30, 2021 | -199.65% |
| Mar 31, 2021 | 366.62% |
| Dec 31, 2020 | 17.20% |
| Sep 30, 2020 | 88.34% |
| Jun 30, 2020 | 107.12% |
| Mar 31, 2020 | -70.02% |